The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-amino-4-(5-(4-(((R)-1-phenylpropan-2-yl)oxy)phenyl)-2H-tetrazol-2-yl)butanoic acid ID: ALA4870263
PubChem CID: 164621539
Max Phase: Preclinical
Molecular Formula: C20H23N5O3
Molecular Weight: 381.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](Cc1ccccc1)Oc1ccc(-c2nnn(C[C@@H](N)CC(=O)O)n2)cc1
Standard InChI: InChI=1S/C20H23N5O3/c1-14(11-15-5-3-2-4-6-15)28-18-9-7-16(8-10-18)20-22-24-25(23-20)13-17(21)12-19(26)27/h2-10,14,17H,11-13,21H2,1H3,(H,26,27)/t14-,17+/m1/s1
Standard InChI Key: KXEKRRRRNMXMJG-PBHICJAKSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
39.0587 -28.9318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0575 -29.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7656 -30.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4752 -29.7509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4724 -28.9282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7638 -28.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3495 -30.1594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.1763 -28.5186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9241 -28.8482 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4687 -28.2388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.0574 -27.5326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.2587 -27.7056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.2817 -28.3212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7595 -27.6583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5726 -27.7406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0504 -27.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.8634 -27.1600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.7152 -26.3324 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.4243 -26.9130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.6421 -29.7503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9341 -30.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2267 -29.7491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2321 -28.9309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5256 -28.5219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8165 -28.9300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8185 -29.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5257 -30.1568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6428 -28.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
5 8 1 0
10 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
14 19 1 1
7 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
20 28 1 1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 381.44Molecular Weight (Monoisotopic): 381.1801AlogP: 2.15#Rotatable Bonds: 9Polar Surface Area: 116.15Molecular Species: ZWITTERIONHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.33CX Basic pKa: 9.94CX LogP: 0.88CX LogD: 0.88Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -0.94
References 1. Markert C, Thoma G, Srinivas H, Bollbuck B, Lüönd RM, Miltz W, Wälchli R, Wolf R, Hinrichs J, Bergsdorf C, Azzaoui K, Penno CA, Klein K, Wack N, Jäger P, Hasler F, Beerli C, Loetscher P, Dawson J, Wieczorek G, Numao S, Littlewood-Evans A, Röhn TA.. (2021) Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A4 Hydrolase., 64 (4.0): [PMID:33592148 ] [10.1021/acs.jmedchem.0c01955 ]